|
UNITED STATES |
OMB APPROVAL |
|
SECURITIES AND EXCHANGE COMMISSION |
OMB Number: 3235-0578 |
|
Expires: April 30, 2013 | |
|
Estimated average burden hours per response......5.6 |
FORM N-PX
ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY
Investment Company Act file number 811- 06565
H&Q Life Sciences Investors
(Exact name of registrant as specified in charter)
2 Liberty Square, 9th Floor, Boston, MA |
|
02109 |
(Address of principal executive offices) |
|
(Zip code) |
Laura Woodward H&Q Life Sciences Investors 2 Liberty Square, 9th Floor, Boston MA 02109 |
(Name and address of agent for service) |
Registrants telephone number, including area code: 617-772-8500 |
| ||
| |||
Date of fiscal year end: September 30 |
| ||
| |||
Date of reporting period: 7/1/11-6/30/12 |
| ||
Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss. 239.24 and 274.5 of this chapter), to file reports with the Commission, no later than August 31 of each year, containing the registrants proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.
A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (OMB) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.
Item 1. Proxy Voting Record.
ACORDA THERAPEUTICS, INC.
Security |
00484M106 |
|
Meeting Type |
Annual |
Ticker Symbol |
ACOR |
|
Meeting Date |
06-Jun-2012 |
ISIN |
US00484M1062 |
|
Agenda |
933614364 - Management |
Record Date |
09-Apr-2012 |
|
Holding Recon Date |
09-Apr-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
05-Jun-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1. |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 BARRY GREENE |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 IAN SMITH |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
|
TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANYS INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3. |
|
AN ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION. |
|
For |
|
Yes |
|
For |
|
Management |
ADDUS HOMECARE CORPORATION
Security |
006739106 |
|
Meeting Type |
Annual |
Ticker Symbol |
ADUS |
|
Meeting Date |
20-Jun-2012 |
ISIN |
US0067391062 |
|
Agenda |
933633516 - Management |
Record Date |
26-Apr-2012 |
|
Holding Recon Date |
26-Apr-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
19-Jun-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1. |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 MARK L. FIRST |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 R. DIRK ALLISON |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
|
TO RATIFY THE SELECTION OF BDO USA, LLP AS INDEPENDENT AUDITOR OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2012. |
|
For |
|
Yes |
|
For |
|
Management |
AEGERION PHARMACEUTICALS, INC.
Security |
00767E102 |
|
Meeting Type |
Annual |
Ticker Symbol |
AEGR |
|
Meeting Date |
05-Jun-2012 |
ISIN |
US00767E1029 |
|
Agenda |
933611647 - Management |
Record Date |
09-Apr-2012 |
|
Holding Recon Date |
09-Apr-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
04-Jun-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1. |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 SANDFORD D. SMITH |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 PAUL G. THOMAS |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
|
TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS AEGERION PHARMACEUTICALS, INC.S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012. |
|
For |
|
Yes |
|
For |
|
Management |
AKORN, INC.
Security |
009728106 |
|
Meeting Type |
Special |
Ticker Symbol |
AKRX |
|
Meeting Date |
29-Dec-2011 |
ISIN |
US0097281069 |
|
Agenda |
933536457 - Management |
Record Date |
05-Dec-2011 |
|
Holding Recon Date |
05-Dec-2011 |
City / Country |
/ |
United States |
Vote Deadline Date |
28-Dec-2011 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
01 |
|
APPROVAL OF AN AMENDMENT TO THE AMENDED AND RESTATED AKORN, INC. 2003 STOCK OPTION PLAN TO INCREASE THE TOTAL NUMBER OF SHARES OF COMMON STOCK AUTHORIZED AND RESERVED FOR ISSUANCE UNDER THE PLAN FROM 11,000,000 TO 19,000,000 SHARES. |
|
For |
|
Yes |
|
For |
|
Management |
AKORN, INC.
Security |
009728106 |
|
Meeting Type |
Annual |
Ticker Symbol |
AKRX |
|
Meeting Date |
04-May-2012 |
ISIN |
US0097281069 |
|
Agenda |
933610760 - Management |
Record Date |
19-Mar-2012 |
|
Holding Recon Date |
19-Mar-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
03-May-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1. |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 JOHN N. KAPOOR, PHD |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 RONALD M. JOHNSON |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 BRIAN TAMBI |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 STEVEN J. MEYER |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 ALAN WEINSTEIN |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 KENNETH S. ABRAMOWITZ |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7 ADRIENNE L. GRAVES, PHD |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
|
PROPOSAL TO RATIFY THE SELECTION OF ERNST & YOUNG LLP TO SERVE AS AKORNS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3. |
|
SAY ON PAY - AN ADVISORY VOTE ON APPROVAL OF THE COMPANYS EXECUTIVE COMPENSATION PROGRAM. |
|
For |
|
Yes |
|
For |
|
Management |
ALEXION PHARMACEUTICALS, INC.
Security |
015351109 |
|
Meeting Type |
Annual |
Ticker Symbol |
ALXN |
|
Meeting Date |
07-May-2012 |
ISIN |
US0153511094 |
|
Agenda |
933610772 - Management |
Record Date |
16-Mar-2012 |
|
Holding Recon Date |
16-Mar-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
04-May-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1. |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 LEONARD BELL |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 MAX LINK |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 WILLIAM R. KELLER |
|
For |
|
Yes |
|
For |
|
|
|
|
4 JOSEPH A. MADRI |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 LARRY L. MATHIS |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 R. DOUGLAS NORBY |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7 ALVIN S. PARVEN |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8 ANDREAS RUMMELT |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9 ANN M. VENEMAN |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
|
RATIFICATION OF APPOINTMENT BY THE BOARD OF DIRECTORS OF PRICEWATERHOUSECOOPERS LLP AS ALEXIONS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3. |
|
APPROVAL OF A NON-BINDING ADVISORY VOTE OF THE COMPENSATION PAID TO ALEXIONS NAMED EXECUTIVE OFFICERS. |
|
For |
|
Yes |
|
For |
|
Management |
ALKERMES PLC
Security |
G01767105 |
|
Meeting Type |
Special |
Ticker Symbol |
ALKS |
|
Meeting Date |
08-Dec-2011 |
ISIN |
IE00B56GVS15 |
|
Agenda |
933524604 - Management |
Record Date |
01-Nov-2011 |
|
Holding Recon Date |
01-Nov-2011 |
City / Country |
/ |
United States |
Vote Deadline Date |
07-Dec-2011 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
01 |
|
TO APPROVE THE ALKERMES PLC 2011 STOCK OPTION AND INCENTIVE PLAN. |
|
For |
|
Yes |
|
For |
|
Management |
ALKERMES, INC.
Security |
01642T108 |
|
Meeting Type |
Special |
Ticker Symbol |
ALKS |
|
Meeting Date |
08-Sep-2011 |
ISIN |
US01642T1088 |
|
Agenda |
933496019 - Management |
Record Date |
01-Aug-2011 |
|
Holding Recon Date |
01-Aug-2011 |
City / Country |
/ |
United States |
Vote Deadline Date |
07-Sep-2011 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
01 |
|
TO ADOPT THE BUSINESS COMBINATION AGREEMENT AND PLAN OF MERGER, DATED AS OF MAY 9, 2011, BY AND AMONG ELAN CORPORATION, PLC, ALKERMES, INC., ANTLER SCIENCE TWO LIMITED, ANTLER ACQUISITION CORP. AND CERTAIN OTHER PARTIES AS DESCRIBED IN THE PROXY STATEMENT/PROSPECTUS, PURSUANT TO WHICH ANTLER ACQUISITION CORP. WILL MERGE WITH AND INTO ALKERMES, INC. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
02 |
|
TO APPROVE THE CREATION OF DISTRIBUTABLE RESERVES OF ALKERMES PLC THROUGH A REDUCTION OF THE SHARE PREMIUM ACCOUNT OF ALKERMES PLC (THAT WAS PREVIOUSLY APPROVED BY THE CURRENT SHAREHOLDERS OF ALKERMES PLC) AS DESCRIBED IN THE PROXY STATEMENT/PROSPECTUS. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
03 |
|
TO ADJOURN THE SPECIAL MEETING TO A LATER DATE OR DATES IF NECESSARY OR APPROPRIATE, INCLUDING FOR THE PURPOSE OF PERMITTING FURTHER SOLICITATION OF PROXIES. |
|
For |
|
Yes |
|
For |
|
Management |
AMARIN CORPORATION PLC
Security |
023111206 |
|
Meeting Type |
Annual |
Ticker Symbol |
AMRN |
|
Meeting Date |
12-Jul-2011 |
ISIN |
US0231112063 |
|
Agenda |
933458336 - Management |
Record Date |
29-Apr-2011 |
|
Holding Recon Date |
29-Apr-2011 |
City / Country |
/ |
United States |
Vote Deadline Date |
05-Jul-2011 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
O1 |
|
ORDINARY RESOLUTION TO RE-ELECT DR. JOSEPH ANDERSON AS A DIRECTOR. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O2 |
|
ORDINARY RESOLUTION TO RE-ELECT DR. JAMES I. HEALY AS A DIRECTOR. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O3 |
|
ORDINARY RESOLUTION TO ELECT MS. KRISTINE PETERSON AS A DIRECTOR. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O4 |
|
ORDINARY RESOLUTION TO ELECT DR. DAVID FEIGAL AS A DIRECTOR. |
|
For |
|
Yes |
|
For |
|
Management |
O5 |
|
ORDINARY RESOLUTION (ADVISORY, NON-BINDING VOTE) ON THE COMPANYS EXECUTIVE COMPENSATION. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O6 |
|
ORDINARY RESOLUTION (ADVISORY, NON-BINDING VOTE) ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON EXECUTIVE COMPENSATION. |
|
1 Year |
|
Yes |
|
1 Year |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O7 |
|
ORDINARY RESOLUTION (ADVISORY, NON-BINDING VOTE) ON THE DIRECTORS REMUNERATION REPORT FOR THE FISCAL YEAR ENDED DECEMBER 31, 2010. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O8 |
|
ORDINARY RESOLUTION TO RE-APPOINT DELOITTE & TOUCHE LLP AS AUDITORS OF THE COMPANY AND TO AUTHORISE THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF THE COMPANY TO FIX THEIR REMUNERATION. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
S9 |
|
SPECIAL RESOLUTION TO ADOPT AND APPROVE THE AMARIN CORPORATION PLC 2011 STOCK INCENTIVE PLAN. |
|
For |
|
Yes |
|
For |
|
Management |
AMGEN INC.
Security |
031162100 |
|
Meeting Type |
Annual |
Ticker Symbol |
AMGN |
|
Meeting Date |
23-May-2012 |
ISIN |
US0311621009 |
|
Agenda |
933583937 - Management |
Record Date |
26-Mar-2012 |
|
Holding Recon Date |
26-Mar-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
22-May-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1A. |
|
ELECTION OF DIRECTOR: DR. DAVID BALTIMORE |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1B. |
|
ELECTION OF DIRECTOR: MR. FRANK J. BIONDI, JR. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1C. |
|
ELECTION OF DIRECTOR: MR. ROBERT A. BRADWAY |
|
For |
|
Yes |
|
For |
|
Management |
1D. |
|
ELECTION OF DIRECTOR: MR. FRANCOIS DE CARBONNEL |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1E. |
|
ELECTION OF DIRECTOR: DR. VANCE D. COFFMAN |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1F. |
|
ELECTION OF DIRECTOR: DR. REBECCA M. HENDERSON |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1G. |
|
ELECTION OF DIRECTOR: MR. FRANK C. HERRINGER |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1H. |
|
ELECTION OF DIRECTOR: DR. TYLER JACKS |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1I. |
|
ELECTION OF DIRECTOR: DR. GILBERT S. OMENN |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1J. |
|
ELECTION OF DIRECTOR: MS. JUDITH C. PELHAM |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1K. |
|
ELECTION OF DIRECTOR: ADM. J. PAUL REASON, USN (RETIRED) |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1L. |
|
ELECTION OF DIRECTOR: MR. LEONARD D. SCHAEFFER |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1M. |
|
ELECTION OF DIRECTOR: MR. KEVIN W. SHARER |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1N. |
|
ELECTION OF DIRECTOR: DR. RONALD D. SUGAR |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
2. |
|
TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3. |
|
ADVISORY VOTE TO APPROVE OUR EXECUTIVE COMPENSATION. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
4. |
|
TO APPROVE AN AMENDMENT TO OUR RESTATED CERTIFICATE OF INCORPORATION TO AUTHORIZE STOCKHOLDER ACTION BY WRITTEN CONSENT. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
5A. |
|
STOCKHOLDER PROPOSAL #1 (INDEPENDENT CHAIRMAN OF THE BOARD). |
|
Against |
|
Yes |
|
For |
|
Shareholder |
|
|
|
|
|
|
|
|
|
|
|
5B. |
|
STOCKHOLDER PROPOSAL #2 (TRANSPARENCY IN ANIMAL USE). |
|
Against |
|
Yes |
|
Against |
|
Shareholder |
|
|
|
|
|
|
|
|
|
|
|
5C. |
|
STOCKHOLDER PROPOSAL #3 (REQUEST FOR DISCLOSURE OF LOBBYING POLICIES AND PRACTICES). |
|
Against |
|
Yes |
|
Against |
|
Shareholder |
|
|
|
|
|
|
|
|
|
|
|
5D. |
|
STOCKHOLDER PROPOSAL #4 (CEO TO SERVE ON A MAXIMUM OF ONE OTHER BOARD). |
|
Against |
|
Yes |
|
Against |
|
Shareholder |
BIOGEN IDEC INC.
Security |
09062X103 |
|
Meeting Type |
Annual |
Ticker Symbol |
BIIB |
|
Meeting Date |
08-Jun-2012 |
ISIN |
US09062X1037 |
|
Agenda |
933618843 - Management |
Record Date |
10-Apr-2012 |
|
Holding Recon Date |
10-Apr-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
07-Jun-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1A. |
|
ELECTION OF DIRECTOR: CAROLINE D. DORSA |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1B. |
|
ELECTION OF DIRECTOR: STELIOS PAPADOPOULOS |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1C. |
|
ELECTION OF DIRECTOR: GEORGE A. SCANGOS |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1D. |
|
ELECTION OF DIRECTOR: LYNN SCHENK |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1E. |
|
ELECTION OF DIRECTOR: ALEXANDER J. DENNER |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1F. |
|
ELECTION OF DIRECTOR: NANCY L. LEAMING |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1G. |
|
ELECTION OF DIRECTOR: RICHARD C. MULLIGAN |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1H. |
|
ELECTION OF DIRECTOR: ROBERT W. PANGIA |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1I. |
|
ELECTION OF DIRECTOR: BRIAN S. POSNER |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1J. |
|
ELECTION OF DIRECTOR: ERIC K. ROWINSKY |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1K. |
|
ELECTION OF DIRECTOR: STEPHEN A. SHERWIN |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1L. |
|
ELECTION OF DIRECTOR: WILLIAM D. YOUNG |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
2. |
|
TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS BIOGEN IDECS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3. |
|
SAY ON PAY - AN ADVISORY VOTE ON EXECUTIVE COMPENSATION. |
|
For |
|
Yes |
|
For |
|
Management |
4. |
|
TO APPROVE AN AMENDMENT TO BIOGEN IDECS AMENDED AND RESTATED CERTIFICATE OF INCORPORATION ESTABLISHING DELAWARE AS EXCLUSIVE FORUM FOR CERTAIN DISPUTES. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
5. |
|
TO APPROVE AN AMENDMENT TO BIOGEN IDECS SECOND AMENDED AND RESTATED BYLAWS PERMITTING HOLDERS OF AT LEAST 25% OF COMMON STOCK TO CALL SPECIAL MEETINGS. |
|
For |
|
Yes |
|
For |
|
Management |
BRUKER CORPORATION
Security |
116794108 |
|
Meeting Type |
Annual |
Ticker Symbol |
BRKR |
|
Meeting Date |
18-May-2012 |
ISIN |
US1167941087 |
|
Agenda |
933602636 - Management |
Record Date |
30-Mar-2012 |
|
Holding Recon Date |
30-Mar-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
17-May-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1. |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 RICHARD D. KNISS |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 JOERG C. LAUKIEN |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 WILLIAM A. LINTON |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 CHRIS VAN INGEN |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
|
TO CONSIDER AND ACT UPON A PROPOSAL TO RATIFY, CONFIRM AND APPROVE THE SELECTION OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF BRUKER CORPORATION FOR FISCAL 2012. |
|
For |
|
Yes |
|
For |
|
Management |
CARDIOKINETIX, INC.
Security |
N/A |
|
Meeting Type |
Action by Written Consent |
Ticker Symbol |
N/A |
|
Date |
14-Sep-11 |
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
APPROVE THE AMENDMENT AND RESTATED CERTIFICATE OF INCORPORATION |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
APPROVE THE SALE AND ISSUANCE OF SERIES E PREFFERED STOCK |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
APPROVE WAVIER OF RIGHT OF FIRST OFFER |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
APPROVE THE AMENDMENT TO THE 2002 STOCK PLAN |
|
For |
|
Yes |
|
For |
|
Management |
5 |
|
ELECT DIRECTORS PAUL LA VIOLETTE AND JEANI DELAGARDELLE |
|
For |
|
Yes |
|
For |
|
Management |
6 |
|
APPROVE THE AMENDED AND RESTATED FORM OF IDEMNIFICATION AGREEMENT |
|
For |
|
Yes |
|
For |
|
Management |
7 |
|
APPROVE AMENDMENTS TO THE BYLAWS |
|
For |
|
Yes |
|
For |
|
Management |
8 |
|
APPROVE THE WAIVER OF ANTI-DILUTION ADJUSTMENTS |
|
For |
|
Yes |
|
For |
|
Management |
9 |
|
APPROVE OMNIBUS RESOLUTION |
|
For |
|
Yes |
|
For |
|
Management |
CARDIOKINETIX, INC
Security |
N/A |
|
Meeting Type |
Action by Written Consent |
Ticker Symbol |
N/A |
|
Date |
28-Feb-12 |
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
RATIFICATION OF THE AMENDMENT TO THE 2002 STOCK PLAN |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
APPROVE THE AMENDED AND RESTATED 2002 STOCK PLAN |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
ADOPTION OF THE 2011 EQUITY INCENTIVE PLAN |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
WAVIER ANTI-DILUTION AND PROTECTIVE PROVISIONS |
|
For |
|
Yes |
|
For |
|
Management |
5 |
|
WAVIER OF RIGHT OF FIRST OFFER |
|
For |
|
Yes |
|
For |
|
Management |
6 |
|
APPROVE OMNIBUS RESOLUTION |
|
For |
|
Yes |
|
For |
|
Management |
CELGENE CORPORATION
Security |
151020104 |
|
Meeting Type |
Annual |
Ticker Symbol |
CELG |
|
Meeting Date |
13-Jun-2012 |
ISIN |
US1510201049 |
|
Agenda |
933620189 - Management |
Record Date |
18-Apr-2012 |
|
Holding Recon Date |
18-Apr-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
12-Jun-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1. |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 ROBERT J. HUGIN |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 R.W. BARKER, D. PHIL. |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 MICHAEL D. CASEY |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 CARRIE S. COX |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 RODMAN L. DRAKE |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 M.A. FRIEDMAN, M.D. |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7 GILLA KAPLAN, PH.D. |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8 JAMES J. LOUGHLIN |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9 ERNEST MARIO, PH.D. |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
|
RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE COMPANYS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3. |
|
APPROVAL OF AN AMENDMENT TO THE COMPANYS 2008 STOCK INCENTIVE PLAN. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
4. |
|
APPROVAL, BY NON-BINDING VOTE, OF EXECUTIVE COMPENSATION OF THE COMPANYS NAMED EXECUTIVE OFFICERS. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
5. |
|
STOCKHOLDER PROPOSAL DESCRIBED IN MORE DETAIL IN THE PROXY STATEMENT. |
|
Against |
|
Yes |
|
Against |
|
Shareholder |
CELLADON CORPORATION
Security |
N/A |
|
Meeting Type |
Action by Written Consent |
Ticker Symbol |
N/A |
|
Date |
26-Apr-12 |
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
APPROVE THE AMENDMENT TO THE COMPANYS 2012 EQUITY INCENTIVE PLAN. |
|
For |
|
Yes |
|
For |
|
Management |
CERES, INC.
Security |
N/A |
|
Meeting Type |
Action by Written Consent |
Ticker Symbol |
N/A |
|
Date |
9-Dec-11 |
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
APPROVAL OF ALL AMENDMENTS TO THE CERTIFICATE OF AMENDMENT TO THE RESTATED CERTIFICATE OF INCORPORATION |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
APPROVAL OF THE SPONSORED RESARCH AGREEMENT WITH TEXAS A&M UNIVERSITY (TAMU) |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
APPROVAL TO ISSUE TAMU WARRANT TO PURCHASE SHARES OF THE CORPORATIONSS COMMON STOCK |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
AUTHORIZATION AND ISSUANCE OF ANY EQUITY SECURITY BY THE CORPORATION PURSUANT TO THE CORPORATIONS RESTATED CERTIFICATE OF INCORPORATION |
|
For |
|
Yes |
|
For |
|
Management |
5 |
|
APPROVAL AND CONSENT TO THE ISSUANCE OF WARRANTS TO PURCHASE UP TO AN AGGREGATE OF 200,000 SHARES OF THE CORPORATIONS COMMON STOCK TO TAMU |
|
For |
|
Yes |
|
For |
|
Management |
6 |
|
APPROVAL THAT THE OFFICERS OF THE CORPORATION BE AUTHORIZED AND DIRECTED ON BEHALF OF THE CORPORATION, TO EXECUTE ALL DOCUMENTS AND TAKE SUCH FURTHER ACTION AS THEY DEEM NECESSARY, APPROPRIATE OR ADVISABLE. |
|
For |
|
Yes |
|
For |
|
Management |
7 |
|
CONVERTIBLE NOTE OFFERING WAIVER |
|
For |
|
Yes |
|
For |
|
Management |
8 |
|
AUTHORIZATION TO ISSUE AND SELL CONVERTIBLE NOTES |
|
For |
|
Yes |
|
For |
|
Management |
9 |
|
WAIVER AND CONSENT |
|
For |
|
Yes |
|
For |
|
Management |
CERES, INC.
Security |
N/A |
|
Meeting Type |
Annual |
Ticker Symbol |
N/A |
|
Meeting Date |
17-Jan-12 |
Record Date |
14-Dec-11 |
|
|
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
TO ELECT ELEVEN DIRECTORS TO SERVE UNTIL THE 2013 ANNUAL STOCKHOLDERS MEETING |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
TO RATIFY KPMG AS INDEPENDENT ACCOUNTANTS FOR THE FISCAL YEAR. |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
TO CONSIDER OTHER SUCH BUSINESS AS MAY PROPERLY COME BEFORE THE MEETING |
|
For |
|
Yes |
|
For |
|
Management |
CONCENTRIC MEDICAL, INC.
Security |
N/A |
|
Meeting Type |
Action by Written Consent |
Ticker Symbol |
N/A |
|
Date |
31-Aug-11 |
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
ADOPTION OF THE MERGER DOCUMENTS |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
CONSENTS AND TERMINATION OF OTHER AGREEMENTS |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
OMNIBUS RESOLUTIONS |
|
For |
|
Yes |
|
For |
|
Management |
CORNERSTONE THERAPEUTICS INC
Security |
21924P103 |
|
Meeting Type |
Annual |
Ticker Symbol |
CRTX |
|
Meeting Date |
22-May-2012 |
ISIN |
US21924P1030 |
|
Agenda |
933610859 - Management |
Record Date |
30-Mar-2012 |
|
Holding Recon Date |
30-Mar-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
21-May-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1. |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 CRAIG A. COLLARD |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 ALESSANDRO CHIESI |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 CHRISTOPHER CODEANNE |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 MICHAEL ENRIGHT |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 ANTON GIORGIO FAILLA |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 JAMES HARPER |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7 MICHAEL HEFFERNAN |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8 ROBERT M. STEPHAN |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9 MARCO VECCHIA |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
|
RATIFICATION OF THE SELECTION BY THE AUDIT COMMITTEE OF ERNST AND YOUNG LLP AS THE COMPANYS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012. |
|
For |
|
Yes |
|
For |
|
Management |
COVANCE INC.
Security |
222816100 |
|
Meeting Type |
Annual |
Ticker Symbol |
CVD |
|
Meeting Date |
08-May-2012 |
ISIN |
US2228161004 |
|
Agenda |
933573049 - Management |
Record Date |
14-Mar-2012 |
|
Holding Recon Date |
14-Mar-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
07-May-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1. |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 R. BARCHI, M.D., PH.D. |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 JOSEPH C. SCODARI |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
|
ADVISORY APPROVAL OF THE COMPANYS EXECUTIVE COMPENSATION. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3. |
|
APPROVAL OF THE NON-EMPLOYEE DIRECTORS DEFERRED STOCK PLAN. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
4. |
|
RATIFICATION OF APPOINTMENT OF ERNST & YOUNG LLC FOR THE FISCAL YEAR 2012. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
5. |
|
SHAREHOLDER PROPOSAL SUBMITTED BY PETA TO REQUIRE ANNUAL REPORTS BY THE BOARD OF DIRECTORS PERTAINING TO CITATIONS UNDER THE ANIMAL WELFARE ACT. |
|
Against |
|
Yes |
|
Against |
|
Shareholder |
CURIS, INC.
Security |
231269101 |
|
Meeting Type |
Annual |
Ticker Symbol |
CRIS |
|
Meeting Date |
30-May-2012 |
ISIN |
US2312691015 |
|
Agenda |
933599714 - Management |
Record Date |
02-Apr-2012 |
|
Holding Recon Date |
02-Apr-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
29-May-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1. |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 JAMES R. MCNAB, JR. |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 JAMES R. TOBIN |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
|
TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANYS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE CURRENT FISCAL YEAR. |
|
For |
|
Yes |
|
For |
|
Management |
DENDREON CORPORATION
Security |
24823Q107 |
|
Meeting Type |
Annual |
Ticker Symbol |
DNDN |
|
Meeting Date |
13-Jun-2012 |
ISIN |
US24823Q1076 |
|
Agenda |
933624303 - Management |
Record Date |
18-Apr-2012 |
|
Holding Recon Date |
18-Apr-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
12-Jun-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1.1 |
|
ELECTION OF DIRECTOR: JOHN H. JOHNSON |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1.2 |
|
ELECTION OF DIRECTOR: SUSAN B. BAYH |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1.3 |
|
ELECTION OF DIRECTOR: DENNIS M. FENTON, PH.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1.4 |
|
ELECTION OF DIRECTOR: DAVID L. URDAL, PH.D. |
|
For |
|
Yes |
|
For |
|
Management |
2. |
|
TO APPROVE AN AMENDMENT TO THE DENDREON CORPORATION 2009 EQUITY INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES AUTHORIZED FOR ISSUANCE THEREUNDER FROM 13,200,000 TO 22,200,000. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3. |
|
TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANYS NAMED EXECUTIVE OFFICERS. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
4. |
|
TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANYS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012. |
|
For |
|
Yes |
|
For |
|
Management |
ELAN CORPORATION, PLC
Security |
284131208 |
|
Meeting Type |
Annual |
Ticker Symbol |
ELN |
|
Meeting Date |
24-May-2012 |
ISIN |
US2841312083 |
|
Agenda |
933623046 - Management |
Record Date |
16-Apr-2012 |
|
Holding Recon Date |
16-Apr-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
17-May-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
O1 |
|
TO RECEIVE AND CONSIDER THE FINANCIAL STATEMENTS, DIRECTORS REPORT AND AUDITORS REPORT FOR THE YEAR ENDED 31 DECEMBER 2011. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O2 |
|
TO RE-ELECT DR. LARS EKMAN. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O3 |
|
TO ELECT MR. HANS PETER HASLER. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O4 |
|
TO RE-ELECT MR. ROBERT INGRAM. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O5 |
|
TO RE-ELECT MR. GARY KENNEDY. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O6 |
|
TO RE-ELECT MR. PATRICK KENNEDY. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O7 |
|
TO RE-ELECT MR. GILES KERR. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O8 |
|
TO RE-ELECT MR. KELLY MARTIN. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O9 |
|
TO RE-ELECT MR. KIERAN MCGOWAN. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O10 |
|
TO RE-ELECT MR. KYRAN MCLAUGHLIN. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O11 |
|
TO RE-ELECT MR. DONAL OCONNOR. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O12 |
|
TO RE-ELECT MR. RICHARD PILNIK. |
|
For |
|
Yes |
|
For |
|
Management |
O13 |
|
TO RE-ELECT DR. DENNIS SELKOE. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O14 |
|
TO ELECT DR. ANDREW VON ESCHENBACH. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O15 |
|
TO AUTHORISE THE DIRECTORS TO FIX THE REMUNERATION OF THE AUDITORS. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O16 |
|
TO APPROVE AND ADOPT THE ELAN CORPORATION, PLC 2012 LONG TERM INCENTIVE PLAN. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O17 |
|
TO APPROVE AND ADOPT THE ELAN CORPORATION, PLC EMPLOYEE EQUITY PURCHASE PLAN (2012 AMENDMENT). |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O18 |
|
TO AUTHORISE THE DIRECTORS TO ALLOT AND ISSUE RELEVANT SECURITIES. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
S19 |
|
TO AUTHORISE THE DISAPPLICATION OF PRE-EMPTION RIGHTS. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
S20 |
|
TO REDUCE THE COMPANYS SHARE CAPITAL. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
S21 |
|
TO CONVERT THE EXECUTIVE SHARES TO REDEEMABLE EXECUTIVE SHARES. |
|
For |
|
N/A |
|
Abstain |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
S22 |
|
TO AMEND THE ARTICLES OF ASSOCIATION. |
|
For |
|
N/A |
|
Abstain |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
S23 |
|
TO AUTHORISE THE COMPANY TO MAKE MARKET PURCHASES OF ITS OWN SHARES. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
S24 |
|
TO SET THE RE-ISSUE PRICE RANGE FOR TREASURY SHARES. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
S25 |
|
TO RETAIN A 14 DAY NOTICE PERIOD FOR EXTRAORDINARY GENERAL MEETINGS. |
|
For |
|
Yes |
|
For |
|
Management |
ENDO PHARMACEUTICALS HOLDINGS INC.
Security |
29264F205 |
|
Meeting Type |
Annual |
Ticker Symbol |
ENDP |
|
Meeting Date |
23-May-2012 |
ISIN |
US29264F2056 |
|
Agenda |
933623957 - Management |
Record Date |
09-Apr-2012 |
|
Holding Recon Date |
09-Apr-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
22-May-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1A. |
|
ELECTION OF DIRECTOR: ROGER H. KIMMEL |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1B. |
|
ELECTION OF DIRECTOR: JOHN J. DELUCCA |
|
For |
|
Yes |
|
For |
|
Management |
1C. |
|
ELECTION OF DIRECTOR: DAVID P. HOLVECK |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1D. |
|
ELECTION OF DIRECTOR: NANCY J. HUTSON, PH.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1E. |
|
ELECTION OF DIRECTOR: MICHAEL HYATT |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1F. |
|
ELECTION OF DIRECTOR: WILLIAM P. MONTAGUE |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1G. |
|
ELECTION OF DIRECTOR: DAVID B. NASH, M.D., M.B.A. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1H. |
|
ELECTION OF DIRECTOR: JOSEPH C. SCODARI |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1I. |
|
ELECTION OF DIRECTOR: WILLIAM F. SPENGLER |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
2. |
|
TO RATIFY THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANYS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2012. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3. |
|
TO APPROVE, BY ADVISORY VOTE, NAMED EXECUTIVE OFFICER COMPENSATION. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
4. |
|
TO APPROVE THE AMENDMENT AND RESTATEMENT TO THE COMPANYS AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO CHANGE THE NAME OF THE COMPANY TO ENDO HEALTH SOLUTIONS INC. |
|
For |
|
Yes |
|
For |
|
Management |
GEN-PROBE INCORPORATED
Security |
36866T103 |
|
Meeting Type |
Annual |
Ticker Symbol |
GPRO |
|
Meeting Date |
17-May-2012 |
ISIN |
US36866T1034 |
|
Agenda |
933591213 - Management |
Record Date |
23-Mar-2012 |
|
Holding Recon Date |
23-Mar-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
16-May-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1. |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 JOHN W. BROWN |
|
For |
|
Yes |
|
For |
|
|
|
|
2 JOHN C. MARTIN, PH.D. |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
|
TO APPROVE THE AMENDMENT AND RESTATEMENT OF THE GEN-PROBE INCORPORATED EMPLOYEE STOCK PURCHASE PLAN. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3. |
|
TO APPROVE THE GEN-PROBE INCORPORATED 2012 EXECUTIVE BONUS PLAN. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
4. |
|
TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS OF GEN-PROBE INCORPORATED. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
5. |
|
TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF GEN-PROBE INCORPORATED FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012. |
|
For |
|
Yes |
|
For |
|
Management |
GENTIUM S.P.A
Security |
37250B104 |
|
Meeting Type |
Annual |
Ticker Symbol |
GENT |
|
Meeting Date |
09-May-2012 |
ISIN |
US37250B1044 |
|
Agenda |
933576095 - Management |
Record Date |
29-Feb-2012 |
|
Holding Recon Date |
29-Feb-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
30-Apr-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1. |
|
APPROVAL OF THE 2011 ITALIAN GAAP FINANCIAL STATEMENTS AND RELATED DOCUMENTS AND ALLOCATION OF THE ANNUAL OPERATING PROFIT. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
2.A |
|
ELECTION OF DIRECTOR: GIGLIOLA BERTOGLIO |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
2.B |
|
ELECTION OF DIRECTOR: MARCO BRUGHERA |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
2.C |
|
ELECTION OF DIRECTOR: GLENN COOPER |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
2.D |
|
ELECTION OF DIRECTOR: LAURA FERRO |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
2.E |
|
ELECTION OF DIRECTOR: KHALID ISLAM |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
2.F |
|
ELECTION OF DIRECTOR: BOBBY SANDAGE |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
2.G |
|
ELECTION OF DIRECTOR: ELMAR SCHNEE |
|
For |
|
Yes |
|
For |
|
Management |
3. |
|
APPROVE DIRECTOR COMPENSATION FOR THE 2012/2013 TERM. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
4. |
|
ELECT MEMBERS OF THE BOARD OF STATUTORY AUDITORS OF THE COMPANY FOR THE 2012/2015 TERM AND APPROVE THEIR COMPENSATION FOR SUCH TERM. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
5. |
|
APPROVE THE ENGAGEMENT OF RECONTA ERNST & YOUNG S.P.A. AS THE INDEPENDENT AUDITOR FOR FISCAL YEAR 2012 WITH RESPECT TO THE COMPANYS U.S. GAAP FINANCIAL STATEMENTS & ITS COMPENSATION. |
|
For |
|
Yes |
|
For |
|
Management |
GILEAD SCIENCES, INC.
Security |
375558103 |
|
Meeting Type |
Annual |
Ticker Symbol |
GILD |
|
Meeting Date |
10-May-2012 |
ISIN |
US3755581036 |
|
Agenda |
933574483 - Management |
Record Date |
14-Mar-2012 |
|
Holding Recon Date |
14-Mar-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
09-May-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1. |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 JOHN F. COGAN |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 ETIENNE F. DAVIGNON |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 JAMES M. DENNY |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 CARLA A. HILLS |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 KEVIN E. LOFTON |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 JOHN W. MADIGAN |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7 JOHN C. MARTIN |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8 GORDON E. MOORE |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9 NICHOLAS G. MOORE |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10 RICHARD J. WHITLEY |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11 GAYLE E. WILSON |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12 PER WOLD-OLSEN |
|
For |
|
Yes |
|
For |
|
|
2. |
|
TO RATIFY THE SELECTION OF ERNST & YOUNG LLP BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF GILEAD FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3. |
|
TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF GILEADS NAMED EXECUTIVE OFFICERS AS PRESENTED IN THE PROXY STATEMENT. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
4. |
|
IF PROPERLY PRESENTED AT THE MEETING, TO VOTE ON A STOCKHOLDER PROPOSAL REQUESTING THAT THE BOARD TAKE STEPS TO PERMIT STOCKHOLDER ACTION BY WRITTEN CONSENT. |
|
Against |
|
Yes |
|
Abstain |
|
Shareholder |
|
|
|
|
|
|
|
|
|
|
|
5. |
|
IF PROPERLY PRESENTED AT THE MEETING, TO VOTE ON A STOCKHOLDER PROPOSAL REQUESTING THAT THE BOARD TAKE STEPS TO REDEEM GILEADS POISON PILL UNLESS THE PLAN IS SUBJECT TO A STOCKHOLDER VOTE. |
|
Against |
|
Yes |
|
Abstain |
|
Shareholder |
HUMAN GENOME SCIENCES, INC.
Security |
444903108 |
|
Meeting Type |
Annual |
Ticker Symbol |
HGSI |
|
Meeting Date |
16-May-2012 |
ISIN |
US4449031081 |
|
Agenda |
933584698 - Management |
Record Date |
23-Mar-2012 |
|
Holding Recon Date |
23-Mar-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
15-May-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1. |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 ALLAN BAXTER, PH.D. |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 RICHARD J. DANZIG |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 COLIN GODDARD, PH.D. |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 MAXINE GOWEN, PH.D. |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 TUAN HA-NGOC |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 JERRY KARABELAS, PH.D. |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7 J.L. LAMATTINA, PH.D. |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8 AUGUSTINE LAW LOR |
|
For |
|
Yes |
|
For |
|
|
|
|
9 GEORGE J. MORROW |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10 GREGORY NORDEN |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11 H. THOMAS WATKINS |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12 ROBERT C. YOUNG, M.D. |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
|
TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANYS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3. |
|
TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS. |
|
For |
|
Yes |
|
Against |
|
Management |
ICAD, INC
Security |
44934S107 |
|
Meeting Type |
Annual |
Ticker Symbol |
ICAD |
|
Meeting Date |
22-May-12 |
Record Date |
30-Mar-12 |
|
|
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
TO ELECT DR. LAWRENCE HOWARD |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
TO ELECT KENNETH FERRY |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
TO ELECT DR. RACHEL BREM |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
TO ELECT ANTHONY ECOCK |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
TO ELECT MICHAEL KLEIN |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
TO ELECT STEVEN RAPPAPORT |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
TO ELECT SOMU SUBRAMANIAM |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
TO ELECT DR. ELLIOT SUSSMAN |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
APPROVE AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO EFFECT A REVERSE STOCK SPLIT |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
APPROVE THE 2012 STOCK INCENTIVE PLAN |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
TO RATIFY BDO USA, LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012 |
|
For |
|
Yes |
|
For |
|
Management |
5 |
|
TO TRANSACT SUCH OTHER BUSINESS AS MAY PROPERLY COME BEFORE THE MEETING |
|
For |
|
Yes |
|
For |
|
Management |
ILLUMINA, INC.
Security |
452327109 |
|
Meeting Type |
Contested-Annual |
Ticker Symbol |
ILMN |
|
Meeting Date |
18-Apr-2012 |
ISIN |
US4523271090 |
|
Agenda |
933571110 - Management |
Record Date |
08-Mar-2012 |
|
Holding Recon Date |
08-Mar-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
17-Apr-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
01 |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 A. BLAINE BOWMAN |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 KARIN EASTHAM |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 JAY T. FLATLEY |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 WILLIAM H. RASTETTER |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
02 |
|
TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 30, 2012. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
03 |
|
TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
04 |
|
ROCHES PROPOSAL TO AMEND OUR BYLAWS TO INCREASE THE NUMBER OF DIRECTORS ON THE BOARD OF DIRECTORS. |
|
Against |
|
Yes |
|
For |
|
Shareholder |
05 |
|
ROCHES PROPOSAL TO AMEND THE BYLAWS TO REQUIRE THAT NEWLY CREATED DIRECTORSHIPS BE FILLED ONLY BY A STOCKHOLDER VOTE. |
|
Against |
|
Yes |
|
Against |
|
Shareholder |
|
|
|
|
|
|
|
|
|
|
|
6A |
|
ROCHES PROPOSAL TO FILL THE TWO NEWLY CREATED DIRECTORSHIPS WITH ITS NOMINEES, IF PROPOSAL 4 IS APPROVED EARL (DUKE) COLLIER, JR. |
|
For |
|
Yes |
|
Abstain |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
6B |
|
ROCHES PROPOSAL TO FILL THE TWO NEWLY CREATED DIRECTORSHIPS WITH ITS NOMINEES, IF PROPOSAL 4 IS APPROVED DAVID DODD |
|
For |
|
Yes |
|
Abstain |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
7 |
|
ROCHES PROPOSAL TO REPEAL ANY BYLAW AMENDMENTS ADOPTED BY ILLUMINAS BOARD OF DIRECTORS WITHOUT STOCKHOLDER APPROVAL AFTER APRIL 22, 2010. |
|
Against |
|
Yes |
|
Against |
|
Shareholder |
IMPAX LABORATORIES, INC.
Security |
45256B101 |
|
Meeting Type |
Annual |
Ticker Symbol |
IPXL |
|
Meeting Date |
22-May-2012 |
ISIN |
US45256B1017 |
|
Agenda |
933606658 - Management |
Record Date |
05-Apr-2012 |
|
Holding Recon Date |
05-Apr-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
21-May-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1. |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 LESLIE Z. BENET, PH.D. |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 ROBERT L. BURR |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 ALLEN CHAO, PH.D. |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 N. TEN FLEMING, PH.D. |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 LARRY HSU, PH.D. |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 MICHAEL MARKBREITER |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7 PETER R. TERRERI |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
|
TO APPROVE, BY NON-BINDING VOTE, EXECUTIVE COMPENSATION. |
|
For |
|
Yes |
|
For |
|
Management |
3. |
|
RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012. |
|
For |
|
Yes |
|
For |
|
Management |
INTELLIPHARMACEUTICALS INTERNATIONAL, INC.
Security |
458175101 |
|
Meeting Type |
Special |
Ticker Symbol |
IPCI |
|
Meeting Date |
29-Mar-12 |
Record Date |
N/A |
|
|
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
TO ELECT DIRECTOR DR. ISLA ODIDI |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
TO ELECT DIRECTOR DR. AMINA ODIDI |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
TO ELECT DIRECTOR JOHN ALLPORT |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
TO ELECT DIRECTOR BAHADUR MADHANI |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
TO ELECT DIRECTOR KENNETH KEIRSTEAD |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
TO ELECT DIRECTOR DR. ELDON R. SMITH |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
TO APPROVE THE REAPPOINTMENT OF DELOITTE & TOUCHE AS THE AUDITOR OF THE COMPANY AND TO AUTHORIZE THE DIRECTORS TO FIX THE AUDITORS RENUMERATION |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
THE RESOLUTION APPROVING UNALLOCATED OPTIONS, RIGHTS AND ENTITLEMENTS UNDER THE COMPANYS STOCK OPTION PLAN AS SET OUT IN THE ACCOMPANYING MANAGEMENT PROXY CIRCULAR |
|
For |
|
Yes |
|
For |
|
Management |
INTERLACE MEDICAL, INC
Security |
N/A |
|
Meeting Type |
Action by Written Consent |
Ticker Symbol |
N/A |
|
Date |
14-Nov-11 |
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
APPROVAL OF MERGER |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
APPOINTMENT OF STOCKHOLDERS REPRESENTATIVE |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
GENERAL RESOLUTIONS THAT THE OFFICERS OF THE COMPANY BE AUTHORIZED AND DIRECTED, FOR OR ON BEHALF OF THE COMPANY TO FILE, EXECUTE, VERIFY, ACKNOWLEDGE AND DELIVER ANY AND ALL SUCH CERTIFICATES PURSUANT TO THE MERGER AGREEMENT |
|
For |
|
Yes |
|
For |
|
Management |
KERYX BIOPHARMACEUTICALS, INC.
Security |
492515101 |
|
Meeting Type |
Annual |
Ticker Symbol |
KERX |
|
Meeting Date |
19-Jun-2012 |
ISIN |
US4925151015 |
|
Agenda |
933625432 - Management |
Record Date |
24-Apr-2012 |
|
Holding Recon Date |
24-Apr-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
18-Jun-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 RON BENTSUR |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 KEVIN J. CAMERON |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 JOSEPH FECZKO M.D. |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 WYCHE FOWLER, JR. |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 JACK KAYE |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 MICHAEL P. TARNOK |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2 |
|
THE RATIFICATION OF APPOINTMENT OF UHY LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2012. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3 |
|
THE APPROVAL OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS DISCLOSED IN OUR PROXY STATEMENT. |
|
For |
|
Yes |
|
For |
|
Management |
LIFE TECHNOLOGIES CORPORATION
Security |
53217V109 |
|
Meeting Type |
Annual |
Ticker Symbol |
LIFE |
|
Meeting Date |
26-Apr-2012 |
ISIN |
US53217V1098 |
|
Agenda |
933557994 - Management |
Record Date |
27-Feb-2012 |
|
Holding Recon Date |
27-Feb-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
25-Apr-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1.1 |
|
ELECTION OF DIRECTOR: DONALD W. GRIMM |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1.2 |
|
ELECTION OF DIRECTOR: ORA H. PESCOVITZ, M.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1.3 |
|
ELECTION OF DIRECTOR: PER A. PETERSON, PH.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
2 |
|
RATIFICATION OF APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3 |
|
APPROVAL OF A NON-BINDING ADVISORY RESOLUTION REGARDING THE COMPENSATION OF THE COMPANYS NAMED EXECUTIVE OFFICERS FOR THE FISCAL YEAR ENDED DECEMBER 31, 2011 (NAMED EXECUTIVE OFFICERS). |
|
For |
|
Yes |
|
For |
|
Management |
MAP PHARMACEUTICALS, INC.
Security |
56509R108 |
|
Meeting Type |
Annual |
Ticker Symbol |
MAPP |
|
Meeting Date |
17-May-2012 |
ISIN |
US56509R1086 |
|
Agenda |
933605846 - Management |
Record Date |
02-Apr-2012 |
|
Holding Recon Date |
02-Apr-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
16-May-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1. |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 THOMAS A. ARMER |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 BERNARD J. KELLEY |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 SCOTT R. WARD |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
|
RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. |
|
For |
|
Yes |
|
For |
|
Management |
3. |
|
APPROVAL, BY NON-BINDING VOTE, OF THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS OF MAP PHARMACEUTICALS, INC. |
|
For |
|
Yes |
|
For |
|
Management |
MEDIVATION, INC.
Security |
58501N101 |
|
Meeting Type |
Annual |
Ticker Symbol |
MDVN |
|
Meeting Date |
01-Jul-2011 |
ISIN |
US58501N1019 |
|
Agenda |
933461509 - Management |
Record Date |
13-May-2011 |
|
Holding Recon Date |
13-May-2011 |
City / Country |
/ |
United States |
Vote Deadline Date |
30-Jun-2011 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 DANIEL D. ADAMS |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 GREGORY H. BAILEY, M.D. |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 KIM D. BLICKENSTAFF |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 DAVID T. HUNG, M.D. |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 W. ANTHONY VERNON |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2 |
|
TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANYS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2011. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3 |
|
TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANYS NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
4 |
|
TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF STOCKHOLDER ADVISORY VOTES ON THE COMPENSATION OF THE COMPANYS NAMED EXECUTIVE OFFICERS. |
|
1 Year |
|
Yes |
|
1 Year |
|
Management |
MOMENTA PHARMACEUTICALS, INC.
Security |
60877T100 |
|
Meeting Type |
Annual |
Ticker Symbol |
MNTA |
|
Meeting Date |
13-Jun-2012 |
ISIN |
US60877T1007 |
|
Agenda |
933624036 - Management |
Record Date |
16-Apr-2012 |
|
Holding Recon Date |
16-Apr-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
12-Jun-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1. |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 JOHN K. CLARKE |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 JAMES R. SULAT |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 CRAIG A. WHEELER |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
|
TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE COMPANYS BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS THE COMPANYS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3. |
|
TO VOTE ON A NON-BINDING ADVISORY RESOLUTION ON THE COMPENSATION OF THE COMPANYS NAMED EXECUTIVE OFFICERS. |
|
For |
|
Yes |
|
Against |
|
Management |
MYLAN INC.
Security |
628530107 |
|
Meeting Type |
Annual |
Ticker Symbol |
MYL |
|
Meeting Date |
04-May-2012 |
ISIN |
US6285301072 |
|
Agenda |
933598572 - Management |
Record Date |
23-Mar-2012 |
|
Holding Recon Date |
23-Mar-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
03-May-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1. |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 ROBERT J. COURY |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 RODNEY L. PIATT, C.P.A. |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 HEATHER BRESCH |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 WENDY CAMERON |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 ROBERT J. CINDRICH |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 NEIL DIMICK, C.P.A. |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7 DOUGLAS J. LEECH C.P.A. |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8 JOSEPH C. MAROON, MD |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9 MARK W. PARRISH |
|
For |
|
Yes |
|
For |
|
|
|
|
10 C.B. TODD |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11 R.L. VANDERVEEN PHD RPH |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
|
RATIFY APPOINTMENT OF DELOITTE & TOUCHE LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3. |
|
APPROVE AN AMENDED AND RESTATED 2003 LONG-TERM INCENTIVE PLAN |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
4. |
|
ADVISORY VOTE ON EXECUTIVE COMPENSATION |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
5. |
|
SHAREHOLDER PROPOSAL - DISCLOSURE OF POLITICAL CONTRIBUTIONS |
|
Against |
|
Yes |
|
Against |
|
Shareholder |
|
|
|
|
|
|
|
|
|
|
|
6. |
|
SHAREHOLDER PROPOSAL - SEPARATION OF CHAIRMAN AND CEO POSITIONS |
|
Against |
|
Yes |
|
Against |
|
Shareholder |
NEUROCRINE BIOSCIENCES, INC.
Security |
64125C109 |
|
Meeting Type |
Annual |
Ticker Symbol |
NBIX |
|
Meeting Date |
23-May-2012 |
ISIN |
US64125C1099 |
|
Agenda |
933612663 - Management |
Record Date |
02-Apr-2012 |
|
Holding Recon Date |
02-Apr-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
22-May-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 W. THOMAS MITCHELL |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 JOSEPH A. MOLLICA |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2 |
|
ADVISORY VOTE TO APPROVE THE COMPENSATION PAID TO THE COMPANYS NAMED EXECUTIVE OFFICERS. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3 |
|
TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANYS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012. |
|
For |
|
Yes |
|
For |
|
Management |
NPS PHARMACEUTICALS, INC.
Security |
62936P103 |
|
Meeting Type |
Annual |
Ticker Symbol |
NPSP |
|
Meeting Date |
16-May-2012 |
ISIN |
US62936P1030 |
|
Agenda |
933593281 - Management |
Record Date |
26-Mar-2012 |
|
Holding Recon Date |
26-Mar-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
15-May-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 MICHAEL W. BONNEY |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 COLIN BROOM |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 GEORGES GEMAYEL |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 PEDRO GRANADILLO |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 JAMES G. GRONINGER |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 FRANCOIS NADER |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7 RACHEL R. SELISKER |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8 PETER G. TOMBROS |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2 |
|
ADVISORY VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3 |
|
TO RATIFY THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012. |
|
For |
|
Yes |
|
For |
|
Management |
ONCOGENEX PHARMACEUTICALS, INC
Security |
68230A106 |
|
Meeting Type |
Annual |
Ticker Symbol |
OGXI |
|
Meeting Date |
31-May-2012 |
ISIN |
US68230A1060 |
|
Agenda |
933618615 - Management |
Record Date |
02-Apr-2012 |
|
Holding Recon Date |
02-Apr-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
30-May-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1. |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 SCOTT CORMACK |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 NEIL CLENDENINN |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 JACK GOLDSTEIN |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 MARTIN MATTINGLY |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 STEWART PARKER |
|
For |
|
Yes |
|
For |
|
|
|
|
6 DAVID SMITH |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
|
TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012. |
|
For |
|
Yes |
|
For |
|
Management |
ONYX PHARMACEUTICALS, INC.
Security |
683399109 |
|
Meeting Type |
Annual |
Ticker Symbol |
ONXX |
|
Meeting Date |
21-May-2012 |
ISIN |
US6833991093 |
|
Agenda |
933589179 - Management |
Record Date |
22-Mar-2012 |
|
Holding Recon Date |
22-Mar-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
18-May-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1. |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 PAUL GODDARD |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 ANTONIO J. GRILLO LOPEZ |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 WENDELL WIERENGA |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
|
TO APPROVE AN AMENDMENT TO THE COMPANYS 2005 EQUITY PLAN TO, AMONG OTHER THINGS, INCREASE THE AGGREGATE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE PLAN BY 2,000,000 SHARES. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3. |
|
TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANYS NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
4. |
|
TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS THE COMPANYS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012. |
|
For |
|
Yes |
|
For |
|
Management |
PALOMAR MEDICAL TECHNOLOGIES, INC.
Security |
697529303 |
|
Meeting Type |
Annual |
Ticker Symbol |
PMTI |
|
Meeting Date |
16-May-2012 |
ISIN |
US6975293035 |
|
Agenda |
933585183 - Management |
Record Date |
22-Mar-2012 |
|
Holding Recon Date |
22-Mar-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
15-May-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1. |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 JOSEPH P. CARUSO |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 JEANNE COHANE |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 DAMIAN N. DELLANNO |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 NICHOLAS P. ECONOMOU |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 JAMES G. MARTIN |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 A. NEIL PAPPALARDO |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7 LOUIS P. VALENTE |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
|
TO APPROVE AN ADVISORY VOTE ON EXECUTIVE COMPENSATION. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3. |
|
TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANYS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
4. |
|
TO CONSIDER AND ACT UPON A STOCKHOLDER PROPOSAL REGARDING MAJORITY VOTING IN DIRECTOR ELECTIONS. |
|
Against |
|
Yes |
|
Against |
|
Shareholder |
PALYON MEDICAL CORPORATION
Security |
N/A |
|
Meeting Type |
Action by Written Consent |
Ticker Symbol |
N/A |
|
Date |
25-Apr-12 |
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
APPROVAL OF BRIDGE FINANCING |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
2 |
|
AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3 |
|
APPROVAL OF INCREASE OF SHARES RESERVED UNDER 2009 STOCK OPTION AND INCENTIVE PLAN |
|
For |
|
Yes |
|
For |
|
Management |
PHT CORPORATION
Security |
N/A |
|
Meeting Type |
Action by Written Consent |
Ticker Symbol |
N/A |
|
Date |
27-Jul-11 |
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
APPROVAL THAT THE CORPORTATION IS AUTHORIZED TO ENTER INTO, EXECUTE AND DELIVER, AND PERFORM ITS OBLIGATIONS UNDER, A FIRST LOAN MODIFICATION AGREEMENT |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
2 |
|
APPROVAL THAT THE CORPORATION IS AUTHORIZED AND EMPOWERED, AS SECURITY FOR ANY AND ALL OBLIGATIONS OF THE CORPORATION IN CONNECTION WITH THE FIRST LOAN MODIFICATION AGREEMENT |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3 |
|
APPROVAL THAT THE PRESIDENT, CEO AND CFO ACT AS AUTHORIZED OFFICERS |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
4 |
|
APPROVAL THAT THE AUTHORIZED OFFICERS OF THE CORPORATION BE AUTHORIZED AND EMPOWERED TO EXECUTE AND DELIVER ANY AGREEMENTS ON BEHALF OF THE CORPORATION |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
5 |
|
APPROVAL THAT ALL ACTIONS PREVIOUSLY TAKEN BY AN OFFICER IN CONNECTION WITH THE FOREGOING RESOLUTIONS BE APPROVED, ADOPTED AND RATIFIED IN ALL RESPECTS AS THE ACTS AND DEEDS OF THE CORPORATION |
|
For |
|
Yes |
|
For |
|
Management |
PUMA BIOTECHNOLOGY, INC.
Security |
N/A |
|
Meeting Type |
Action by Written Consent |
Ticker Symbol |
N/A |
|
Date |
4-Oct-11 |
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
AMENDMENT TO THE CERTIFICATE OF INCORPORATION |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
2 |
|
GENERAL AUTHORITY AND RATIFICATION |
|
For |
|
Yes |
|
For |
|
Management |
PUMA BIOTECHNOLOGY, INC
Security |
74587V107 |
|
Meeting Type |
Annual |
Ticker Symbol |
PBYI |
|
Meeting Date |
13-Jun-12 |
Record Date |
16-Apr-12 |
|
|
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
TO ELECT DIRECTORS ALAN H. AUERBACH, THOMAS R. MALLEY AND JAY M. MOYES |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
2 |
|
ADVISORY VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS DESCRIBED IN THE PROXY MATERIALS |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3 |
|
ADVISORY VOTE TO APPROVE THE FREQUENCY OF FUTURE VOTES ON OUR EXECUTIVE COMPENSATION |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
4 |
|
RATIFICATION OF PKF CERIFIED PUBLIC ACCOUNTANTS AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012 |
|
For |
|
Yes |
|
For |
|
Management |
REGENERON PHARMACEUTICALS, INC.
Security |
75886F107 |
|
Meeting Type |
Annual |
Ticker Symbol |
REGN |
|
Meeting Date |
08-Jun-2012 |
ISIN |
US75886F1075 |
|
Agenda |
933614352 - Management |
Record Date |
11-Apr-2012 |
|
Holding Recon Date |
11-Apr-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
07-Jun-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 CHARLES A. BAKER |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 MICHAEL S. BROWN, M.D. |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 ARTHUR F. RYAN |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 GEORGE L. SING |
|
For |
|
Yes |
|
For |
|
|
|
|
5 MARC TESSIER-LAVIGNE |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2 |
|
PROPOSAL TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANYS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012. |
|
For |
|
Yes |
|
For |
|
Management |
SANTARUS, INC.
Security |
802817304 |
|
Meeting Type |
Annual |
Ticker Symbol |
SNTS |
|
Meeting Date |
13-Jun-2012 |
ISIN |
US8028173040 |
|
Agenda |
933619554 - Management |
Record Date |
16-Apr-2012 |
|
Holding Recon Date |
16-Apr-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
12-Jun-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1. |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 GERALD T. PROEHL |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 DAVID F. HALE |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 TED W. LOVE, M.D. |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
|
TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANYS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012. |
|
For |
|
Yes |
|
For |
|
Management |
SHIRE PLC
Security |
82481R106 |
|
Meeting Type |
Annual |
Ticker Symbol |
SHPGY |
|
Meeting Date |
24-Apr-2012 |
ISIN |
US82481R1068 |
|
Agenda |
933576730 - Management |
Record Date |
16-Mar-2012 |
|
Holding Recon Date |
16-Mar-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
16-Apr-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
O1 |
|
TO RECEIVE THE COMPANYS ACCOUNTS FOR THE YEAR ENDED DECEMBER 31, 2011 AND REPORTS OF THE DIRECTORS AND THE AUDITOR. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O2 |
|
TO APPROVE THE DIRECTORS REMUNERATION REPORT FOR THE YEAR ENDED DECEMBER 31, 2011. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O3 |
|
TO RE-ELECT WILLIAM BURNS AS A DIRECTOR OF THE COMPANY. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O4 |
|
TO RE-ELECT MATTHEW EMMENS AS A DIRECTOR OF THE COMPANY. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O5 |
|
TO RE-ELECT DR. DAVID GINSBURG AS A DIRECTOR OF THE COMPANY. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O6 |
|
TO RE-ELECT GRAHAM HETHERINGTON ASA DIRECTOR OF THE COMPANY. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O7 |
|
TO RE-ELECT DAVID KAPPLER AS A DIRECTOR OF THE COMPANY. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O8 |
|
TO RE-ELECT ANNE MINTO AS A DIRECTOR OF THE COMPANY. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O9 |
|
TO RE-ELECT ANGUS RUSSELL AS A DIRECTOR OF THE COMPANY. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O10 |
|
TO RE-ELECT DAVID STOUT AS A DIRECTOR OF THE COMPANY. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O11 |
|
TO ELECT SUSAN KILSBY AS A DIRECTOR OF THE COMPANY. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O12 |
|
TO RE-APPOINT DELOITTE LLP AS THE COMPANYS AUDITOR UNTIL THE CONCLUSION OF THE ANNUAL GENERAL MEETING OF THE COMPANY TO BE HELD IN 2013. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
O13 |
|
TO AUTHORIZE THE AUDIT, COMPLIANCE & RISK COMMITTEE OF THE BOARD TO DETERMINE THE REMUNERATION OF THE AUDITOR. |
|
For |
|
Yes |
|
For |
|
Management |
O14 |
|
TO RESOLVE THAT THE AUTHORITY TO ALLOT RELEVANT SECURITIES (AS DEFINED IN THE COMPANYS ARTICLES OF ASSOCIATION) CONFERRED ON THE DIRECTORS BY ARTICLE 10 PARAGRAPH (B) OF THE COMPANYS ARTICLES OF ASSOCIATION BE RENEWED. ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT. |
|
Against |
|
N/A |
|
Abstain |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
S15 |
|
TO RESOLVE THAT, SUBJECT TO THE PASSING OF RESOLUTION 14, THE AUTHORITY TO ALLOT EQUITY SECURITIES (AS DEFINED IN THE COMPANYS ARTICLES OF ASSOCIATION) WHOLLY FOR CASH, CONFERRED ON THE DIRECTORS BY ARTICLE 10 PARAGRAPH (D) OF THE COMPANYS ARTICLES OF ASSOCIATION BE RENEWED, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT. |
|
Against |
|
N/A |
|
Abstain |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
S16 |
|
TO RESOLVE THAT THE COMPANY BE AND IS HEREBY GENERALLY AND UNCONDITIONALLY AUTHORIZED, PURSUANT TO ARTICLE 57 OF THE COMPANIES (JERSEY) LAW 1991 TO MAKE MARKET PURCHASES OF ORDINARY SHARES IN THE CAPITAL OF THE COMPANY, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
S17 |
|
TO RESOLVE THAT A GENERAL MEETING OF THE COMPANY, OTHER THAN AN ANNUAL GENERAL MEETING, MAY BE CALLED ON NOT LESS THAN 14 CLEAR DAYS NOTICE. |
|
For |
|
Yes |
|
For |
|
Management |
TARGACEPT, INC.
Security |
87611R306 |
|
Meeting Type |
Annual |
Ticker Symbol |
TRGT |
|
Meeting Date |
31-May-2012 |
ISIN |
US87611R3066 |
|
Agenda |
933609236 - Management |
Record Date |
12-Apr-2012 |
|
Holding Recon Date |
12-Apr-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
30-May-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 G. STEVEN BURRILL |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 ERROL B. DE SOUZA |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 MARK SKALETSKY |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2 |
|
ADVISORY VOTE TO APPROVE THE COMPENSATION OF THE COMPANYS NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3 |
|
RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANYS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012 |
|
For |
|
Yes |
|
For |
|
Management |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Security |
881624209 |
|
Meeting Type |
Annual |
Ticker Symbol |
TEVA |
|
Meeting Date |
19-Sep-2011 |
ISIN |
US8816242098 |
|
Agenda |
933499104 - Management |
Record Date |
10-Aug-2011 |
|
Holding Recon Date |
10-Aug-2011 |
City / Country |
/ |
United States |
Vote Deadline Date |
08-Sep-2011 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
01 |
|
APPROVE RESOLUTION OF THE BOARD TO DECLARE & DISTRIBUTE CASH DIVIDEND FOR YEAR DECEMBER 31, 2010, PAID IN FOUR INSTALLMENTS IN AN AGGREGATE AMOUNT OF NIS 2.90 PER ORDINARY SHARE (OR ADS). |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
2A |
|
TO APPOINT MR. CHAIM HURVITZ TO THE BOARD OF DIRECTORS. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
2B |
|
TO APPOINT MR. ORY SLONIM TO THE BOARD OF DIRECTORS. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
2C |
|
TO APPOINT MR. DAN SUESSKIND TO THE BOARD OF DIRECTORS. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3A |
|
APPOINT MR. JOSEPH (YOSSI) NITZANI AS A STATUTORY INDEPENDENT DIRECTOR, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT. |
|
For |
|
Yes |
|
For |
|
Management |
3B |
|
APPOINT PROF. DAFNA SCHWARTZ AS A STATUTORY INDEPENDENT DIRECTOR, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
04 |
|
APPOINT KESSELMAN & KESSELMAN, MEMBER OF PRICEWATERHOUSECOOPERS INTERNATIONAL LTD., AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
05 |
|
TO APPROVE THE PURCHASE OF DIRECTORS & OFFICERS LIABILITY INSURANCE, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
6A |
|
TO APPROVE AN INCREASE IN THE REMUNERATION FOR PROF. MOSHE MANY IN HIS CAPACITY AS VICE CHAIRMAN OF THE BOARD OF DIRECTORS, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT. |
|
For |
|
Yes |
|
Against |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
6B |
|
APPROVE REIMBURSEMENT OF EXPENSES TO DR. PHILLIP FROST, CHAIRMAN OF BOARD, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT. |
|
For |
|
Yes |
|
Against |
|
Management |
THERMO FISHER SCIENTIFIC INC.
Security |
883556102 |
|
Meeting Type |
Annual |
Ticker Symbol |
TMO |
|
Meeting Date |
23-May-2012 |
ISIN |
US8835561023 |
|
Agenda |
933590172 - Management |
Record Date |
26-Mar-2012 |
|
Holding Recon Date |
26-Mar-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
22-May-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1A. |
|
ELECTION OF DIRECTOR: C. MARTIN HARRIS |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1B. |
|
ELECTION OF DIRECTOR: JUDY C. LEWENT |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1C. |
|
ELECTION OF DIRECTOR: JIM P. MANZI |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1D. |
|
ELECTION OF DIRECTOR: LARS R. SORENSEN |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1E. |
|
ELECTION OF DIRECTOR: ELAINE S. ULLIAN |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
2. |
|
AN ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION. |
|
For |
|
Yes |
|
For |
|
Management |
3. |
|
RATIFICATION OF THE AUDIT COMMITTEES SELECTION OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANYS INDEPENDENT AUDITORS FOR 2012. |
|
For |
|
Yes |
|
For |
|
Management |
TIBION CORPORATION
Security |
N/A |
|
Meeting Type |
Action by Written Consent |
Ticker Symbol |
N/A |
|
Date |
23-May-12 |
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
APPROVE THE AMENDMENT AND RESTATED CERTIFICATE OF INCORPORATION |
|
For |
|
Yes |
|
For |
|
Management |
UNITED THERAPEUTICS CORPORATION
Security |
91307C102 |
|
Meeting Type |
Annual |
Ticker Symbol |
UTHR |
|
Meeting Date |
26-Jun-2012 |
ISIN |
US91307C1027 |
|
Agenda |
933631055 - Management |
Record Date |
27-Apr-2012 |
|
Holding Recon Date |
27-Apr-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
25-Jun-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1. |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 MARTINE ROTHBLATT |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 LOUIS SULLIVAN |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 RAY KURZWEIL |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
|
ADVISORY RESOLUTION TO APPROVE EXECUTIVE COMPENSATION |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3. |
|
APPROVAL OF THE UNITED THERAPEUTICS CORPORATION EMPLOYEE STOCK PURCHASE PLAN |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
4. |
|
RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS UNITED THERAPEUTICS CORPORATIONS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2012 |
|
For |
|
Yes |
|
For |
|
Management |
VERASTEM, INC.
Security |
N/A |
|
Meeting Type |
Action by Written Consent |
Ticker Symbol |
N/A |
|
Date |
14-Nov-11 |
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
2 |
|
WAVIER OF PREEMPTIVE RIGHTS |
|
For |
|
Yes |
|
For |
|
Management |
VERASTEM, INC.
Security |
N/A |
|
Meeting Type |
Action by Written Consent |
Ticker Symbol |
N/A |
|
Meeting Date |
15-Nov-11 |
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
APPROVE THE PIONARD LICENSE AGREEMENT |
|
For |
|
Yes |
|
For |
|
Management |
VERASTEM, INC.
Security |
0001526119 |
|
Meeting Type |
Annual |
Ticker Symbol |
VSTM |
|
Meeting Date |
18-Jan-12 |
Record Date |
19-Dec-11 |
|
|
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
TO ELECT DIRECTORS RICH ALDRICH, JOHN K. CLARKE, ANSBERT GADICKE, M.D., STEPHEN KRAUS, HENRI TERMEER AND CHRISTOPH WESTPHAL, M.D., PH.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
2 |
|
TO CONDUCT SUCH OTHER BUSINESS AS MAY PROPERLY COME BEFORE THE ANNUAL MEETING OR ANY ADJOURNMENT OR POSTPONEMENT THEREOF |
|
For |
|
Yes |
|
For |
|
Management |
VERTEX PHARMACEUTICALS INCORPORATED
Security |
92532F100 |
|
Meeting Type |
Annual |
Ticker Symbol |
VRTX |
|
Meeting Date |
16-May-2012 |
ISIN |
US92532F1003 |
|
Agenda |
933606165 - Management |
Record Date |
19-Mar-2012 |
|
Holding Recon Date |
19-Mar-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
15-May-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1. |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 JEFFREY M. LEIDEN |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 BRUCE I. SACHS |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
|
THE APPROVAL OF THE AMENDMENT TO OUR AMENDED AND RESTATED 2006 STOCK AND OPTION PLAN THAT INCREASES THE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE PLAN BY 3,000,000. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3. |
|
THE APPROVAL OF THE AMENDMENT TO OUR EMPLOYEE STOCK PURCHASE PLAN THAT INCREASES THE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE PLAN BY 2,500,000. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
4. |
|
RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2012. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
5. |
|
ADVISORY VOTE ON OUR EXECUTIVE COMPENSATION PROGRAM. |
|
For |
|
Yes |
|
For |
|
Management |
VIVUS, INC.
Security |
928551100 |
|
Meeting Type |
Annual |
Ticker Symbol |
VVUS |
|
Meeting Date |
15-Jun-2012 |
ISIN |
US9285511005 |
|
Agenda |
933627400 - Management |
Record Date |
20-Apr-2012 |
|
Holding Recon Date |
20-Apr-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
14-Jun-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 LELAND F. WILSON |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 PETER Y. TAM |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 MARK B. LOGAN |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 CHARLES J. CASAMENTO |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 LINDA M D SHORTLIFFE MD |
|
For |
|
Yes |
|
For |
|
|
|
|
6 ERNEST MARIO, PH.D. |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2 |
|
TO APPROVE, ON AN ADVISORY BASIS, THE COMPANYS EXECUTIVE COMPENSATION. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3 |
|
RATIFICATION OF THE APPOINTMENT OF OUM & CO. LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF VIVUS, INC. FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012 |
|
For |
|
Yes |
|
For |
|
Management |
WARNER CHILCOTT PUBLIC LIMITED COMPANY
Security |
G94368100 |
|
Meeting Type |
Annual |
Ticker Symbol |
WCRX |
|
Meeting Date |
08-May-2012 |
ISIN |
IE00B446CM77 |
|
Agenda |
933593623 - Management |
Record Date |
12-Mar-2012 |
|
Holding Recon Date |
12-Mar-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
07-May-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1A) |
|
ELECTION OF DIRECTOR: JAMES H. BLOEM |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1B) |
|
ELECTION OF DIRECTOR: ROGER M. BOISSONNEAULT |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1C) |
|
ELECTION OF DIRECTOR: JOHN A. KING, PH.D. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1D) |
|
ELECTION OF DIRECTOR: PATRICK J. OSULLIVAN |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
2. |
|
TO APPROVE THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP, A REGISTERED PUBLIC ACCOUNTING FIRM, AS INDEPENDENT AUDITORS OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012, AND TO AUTHORIZE THE BOARD OF DIRECTORS TO DETERMINE THE AUDITORS REMUNERATION. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3. |
|
TO APPROVE, ON AN ADVISORY BASIS, EXECUTIVE COMPENSATION. |
|
For |
|
Yes |
|
For |
|
Management |
WATSON PHARMACEUTICALS, INC.
Security |
942683103 |
|
Meeting Type |
Annual |
Ticker Symbol |
WPI |
|
Meeting Date |
11-May-2012 |
ISIN |
US9426831031 |
|
Agenda |
933582517 - Management |
Record Date |
16-Mar-2012 |
|
Holding Recon Date |
16-Mar-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
10-May-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1A. |
|
ELECTION OF DIRECTOR: JACK MICHELSON |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1B. |
|
ELECTION OF DIRECTOR: RONALD R. TAYLOR |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
1C. |
|
ELECTION OF DIRECTOR: ANDREW L. TURNER |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
2. |
|
TO APPROVE, ON AN ADVISORY BASIS, NAMED EXECUTIVE OFFICER COMPENSATION. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3. |
|
TO APPROVE AN ANNUAL INCENTIVE PLAN WHICH, IF APPROVED, IS GENERALLY INTENDED TO ALLOW COMPENSATION PAID THEREUNDER TO COVERED EMPLOYEES TO QUALIFY AS QUALIFIED PERFORMANCE-BASED COMPENSATION WITHIN THE MEANING OF 162(M) OF THE UNITED STATES INTERNAL REVENUE CODE (AS AMENDED) (THE CODE). |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
4. |
|
TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANYS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012. |
|
For |
|
Yes |
|
For |
|
Management |
ZOGENIX, INC.
Security |
98978L105 |
|
Meeting Type |
Annual |
Ticker Symbol |
ZGNX |
|
Meeting Date |
06-Jun-2012 |
ISIN |
US98978L1052 |
|
Agenda |
933639126 - Management |
Record Date |
19-Apr-2012 |
|
Holding Recon Date |
19-Apr-2012 |
City / Country |
/ |
United States |
Vote Deadline Date |
05-Jun-2012 |
SEDOL(s) |
|
|
Quick Code |
|
Item |
|
Proposal |
|
Management |
|
Voted |
|
Vote |
|
Sponsor |
|
|
|
|
|
|
|
|
|
|
|
1. |
|
DIRECTOR |
|
|
|
|
|
|
|
Management |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 JAMES C. BLAIR, PH.D. |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 STEPHEN J. FARR, PH.D. |
|
For |
|
Yes |
|
For |
|
|
|
|
3 A M MINOCHERHOMJEE, PHD |
|
For |
|
Yes |
|
For |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
|
RATIFICATION OF THE SELECTION OF ERNST & YOUNG LLP AS ZOGENIXS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
3. |
|
APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE COMPANYS 2010 EQUITY INCENTIVE AWARD PLAN. |
|
For |
|
Yes |
|
For |
|
Management |
|
|
|
|
|
|
|
|
|
|
|
4. |
|
APPROVAL OF AN AMENDMENT TO THE COMPANYS AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE AUTHORIZED NUMBER OF SHARES OF COMMON STOCK FROM 100,000,000 TO 200,000,000. |
|
For |
|
Yes |
|
For |
|
Management |
SIGNATURES
Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
(Registrant) |
H&Q Life Sciences Investors | ||||
| |||||
By (Signature and Title)* |
|
| |||
|
|
| |||
|
/s/ Daniel R. Omstead | ||||
|
(Daniel R. Omstead, President) | ||||
| |||||
Date |
8/31/12 | ||||
*Print the name and title of each signing officer under his or her signature.